These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9841854)

  • 1. Survival of Vibrio vulnificus in whole blood from patients with chronic liver diseases: association with phagocytosis by neutrophils and serum ferritin levels.
    Hor LI; Chang TT; Wang ST
    J Infect Dis; 1999 Jan; 179(1):275-8. PubMed ID: 9841854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired ability of neutrophils to produce oxygen-derived free radicals in patients with chronic liver disease and hepatocellular carcinoma.
    Uehara M; Sato N
    Hepatology; 1994 Aug; 20(2):326-30. PubMed ID: 8045492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil phagocytic and bactericidal function in primary biliary cirrhosis and other chronic liver diseases.
    De Fernandez MA; Clark A; Triger DR
    Clin Exp Immunol; 1987 Mar; 67(3):655-61. PubMed ID: 3608234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge of Vibrio vulnificus infection among Japanese patients with liver diseases: a prospective multicenter study.
    Nagao Y; Matsuoka H; Seike M; Yamasaki K; Kato J; Nakajima T; Miyazaki Y; Ohno T; Inuzuka S; Ohira H; Yokosuka O; Yatsuhashi H; Mori T; Honda K; Kawaguchi T; Ide T; Sata M
    Med Sci Monit; 2009 Oct; 15(10):PH115-120. PubMed ID: 19789520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemochromatosis, iron and septicemia caused by Vibrio vulnificus.
    Bullen JJ; Spalding PB; Ward CG; Gutteridge JM
    Arch Intern Med; 1991 Aug; 151(8):1606-9. PubMed ID: 1872665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of serum indices of iron metabolism and its clinical significance (with a report of 82 cases].
    Wu XL; Xu BY
    Zhonghua Yi Xue Za Zhi; 1985 Nov; 65(11):667-72. PubMed ID: 3006885
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of tissue polypeptide specific antigen as a marker in liver diseases.
    Cetin T; Oğuz A; Algan P; Yildirim IS
    Turk J Gastroenterol; 2003 Sep; 14(3):177-80. PubMed ID: 14655061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship of serum iron and ferritin with the indicators for hepatic fibrosis].
    Huang CW; Bai L; Cai JJ; Guo W; Lan L
    Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):466-8. PubMed ID: 12754132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necrotizing fasciitis from Vibrio vulnificus in a patient with undiagnosed hepatitis and cirrhosis.
    Muldrew KL; Miller RR; Kressin M; Tang YW; Stratton C
    J Clin Microbiol; 2007 Mar; 45(3):1058-62. PubMed ID: 17251404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromogranin A levels in chronic liver disease and hepatocellular carcinoma.
    Massironi S; Fraquelli M; Paggi S; Sangiovanni A; Conte D; Sciola V; Ciafardini C; Colombo M; Peracchi M
    Dig Liver Dis; 2009 Jan; 41(1):31-5. PubMed ID: 18762462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of measurement of serum nuclear matrix protein levels in patients with liver disease.
    Shimizu Y; Nakano I; Katano Y; Shimizu H; Fukuda Y
    Hepatogastroenterology; 2005; 52(66):1809-13. PubMed ID: 16334782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S; Shiota G; Kawasaki H
    Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis B antigen in the serum in chronic liver diseases and malignant hepatoma].
    Libman E; Stojsić S; Marton B; Lemberger J
    Med Pregl; 1981; 34(9-10):389-92. PubMed ID: 6281636
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
    Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological function and nutritional status in patients with hepatocellular carcinoma.
    Iida K; Kadota J; Kawakami K; Shirai R; Abe K; Yoshinaga M; Iwashita T; Matsubara Y; Ishimatsu Y; Ohmagari K; Kohno S
    Hepatogastroenterology; 1999; 46(28):2476-82. PubMed ID: 10522023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vibrio vulnificus infection in patients with liver disease: report of five autopsy cases.
    Chen Y; Satoh T; Tokunaga O
    Virchows Arch; 2002 Jul; 441(1):88-92. PubMed ID: 12111206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New type of wound infection and sepsis caused by the marine vibrio V. vulnificus].
    Ageev AK
    Arkh Patol; 1985; 47(8):89-92. PubMed ID: 3907597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum concentration of alpha 1-antitrypsin in various hepatic diseases].
    Villamil F; Galli B; Sorroche P; Occello M; Gelpi J; Welz G
    Medicina (B Aires); 1986; 46(2):139-42. PubMed ID: 3033426
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M; Onuk MD; Akçay F; Savas MC
    Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.